NEW YORK (GenomeWeb) – Researchers at Leiden University Medical Center have used a genotyping assay and next-generation sequencing workflow developed by ArcherDx to detect gene fusions in sarcoma patients.
The team believes that the assay could eventually be developed into a multiplex diagnostic tool to diagnose rare forms of sarcoma.
Get the full story with
GenomeWeb Premium Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.